ESS vs PPCB · P/E 31, rev $1.89B vs P/E 0.0, $3.9M cap
Essex Property Trust Inc (ESS) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
PPCB does not have a complete income-statement cache yet.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the ESS and PPCB stock pages for the full models.
Not investment advice.